
Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy
Keywords: آدنوزین تری فسفات; ADME; adsorption, distribution, metabolism, and elimination; ADP; adenosine diphosphatase; ATM; ataxia telangiectasia mutated; ATP; adenosine triphosphate; ATR; ataxia telangiectasia and Rad3 related; BRCA1; breast cancer 1; Cdc25a; cell division cycle 25